Portal Biotechnologies

Watertown, MA · Founded 2023 · Privately Held (backing)

Developer of a cell engineering platform designed to enable novel cell analytics and next-generation cell therapies. Portal Biotechnologies is based in Watertown, MA and was founded in 2023. Its last reported valuation was $34.8 million in Dec 2024. It has raised $12 million across 2 recorded rounds; the latest was a $9 million early-stage round in May 2026.

Last reported valuation
$34.8M
Oct 2026
Priced at
—
Total raised
$12.0M
Last round
Early Stage VC
May 2026
How much has Portal Biotechnologies raised?
$12.0Macross 2 recorded rounds · Dec 2024 – May 2026

Most recently, Portal Biotechnologies raised $9.0M in its Early Stage VC (May 2026).

Free account
More of Portal Biotechnologies with a free account
  • ·Watch Portal Biotechnologies: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Portal Biotechnologies round by round

2 rounds
May 2026Early Stage VC$9.0MSEC filing▮
12 investors participated
Dec 2024Early Stage VC$11.7MSEC filing▮
43 investors participated

How much has Portal Biotechnologies raised?

Portal Biotechnologies has raised $12 million across 2 recorded rounds since 2024. The largest was a $9 million early-stage round in May 2026.

Portal Biotechnologies has filed 3 Form Ds with the SEC since 2024, most recently in May 2026 ($11.7 million sold to 43 investors).

Portal Biotechnologies investors

8 investors are on record for Portal Biotechnologies, including Pear (California), Page One Ventures, Scale Good Fund and IA Ventures. The early-stage round in May 2026 drew 12 investors.

For fundraisers
Raising for a company like Portal Biotechnologies?

8 investors have backed Portal Biotechnologies.

See all 8 investors →

Frequently asked about Portal Biotechnologies

How much has Portal Biotechnologies raised?
Portal Biotechnologies has raised $12.0M in total across 2 recorded funding rounds.
When was Portal Biotechnologies's last funding round?
Portal Biotechnologies's most recent recorded round was Early Stage VC in May 2026, raising $9.0M.